EmailPrintShare

News

GHO Capital announces acquisition of DNA Diagnostics Center

13 October 2015 London, UK – GHO Capital, the European specialist healthcare investor, today announces the acquisition of DNA Diagnostics Center (DDC or the Company), a world leader in the provision of specialist DNA-based diagnostic services, for a total transaction value of €104 million. Further details of the transaction were not disclosed. DDC is a…Read more
EmailPrintShare


GHO Capital supports European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference

On Wednesday 18 March 2015, Andrea Ponti, Executive Partner and Founder at GHO Capital, will participate in a panel discussion at the European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference in London. Andrea will be giving an investor’s view on the regulatory environment in Europe. The invitation-only conference is…Read more
EmailPrintShare